Glenmark Pharmaceuticals Limited — Updates, 05-01-2026: General Updates
05-01-2026 | 04:42 pm
05-01-2026 | 04:42 pm
Glenmark Pharma received an unsolicited ESG rating of 71.1 from SES ESG Research, based on publicly available data. The company clarified it did not engage SES ESG for this rating.
No comments yet. Be the first to comment!
